当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2002年第12期
编号:10956269
死亡受体DR5在急性非淋巴细胞白血病细胞中的表达及其临床意义
http://www.100md.com 《第四军医大学学报》 2002年第12期
死亡受体,,死亡受体;脱噬作用;受体,细胞表面;白血病,非淋巴细胞,急性;死亡区域,0引言,1材料和方法,2结果,3讨论,参考文献:
     关键词: 死亡受体;脱噬作用;受体,细胞表面;白血病,非淋巴细胞,急性;死亡区域

    摘 要:目的 探讨死亡受体DR5在急性非淋巴细胞白血病(ANLL)细胞中的表达及其临床意义. 方法 培养Jurkat,NB4细胞和抽取ANLL患者的骨髓细胞,分离出单个核细胞,用免疫组织化学染色的方法测定DR5的阳性表达率,所选病例进行诱导化疗后,研究DR5的阳性表达率与诱导化疗结果的关系. 结果 DR5的阳性表达率在Jurkat细胞中为98%,阳性物质主要分布在胞质及胞膜中;而在NB4细胞中则为81%.不同ANLL患者的DR5阳性细胞的百分率存在较大的差异,其中最高达94%,最低为45%.ANLL患者的DR5阳性表达率与诱导化疗后骨髓涂片的原始和幼稚细胞比例呈负相关,与诱导化疗后的缓解率呈正相关;DR5的阳性表达率与ANLL分型无明显相关. 结论 该结果对ANLL诱导化疗后的疗效判定有一定的参考价值.

    Expression of death receptor5(DR5)in the cells of acute non┐lymphocyte leukemia(ANLL)and its clinical significance

    WANG Yi-Wei SUN Bing-Zhong ZHANG Tao ZHU Hua-Feng HU Pei-Zhen ZHANG Chuan-Shan

    1 Department of Hematology,

    2 Department of Pathology,Xijing Hospital,Fourth Military Medi-cal University,Xi'an710033,China

    Keywords:death receptor;apoptosis;receptors,cell sur-face;leukemia,nonlymphocytic,acute;death domain

    Abstract:AIM To reveal the expression of death receptor5(DR5)in the cells of acute non-lymphocyte leukemia(ANLL)and its clinical significance.METHODS ANLL cell line Jurkat and NB4cells were cultured.Bone marrow cells of ANLL patients were separated.The expressions of DR5in these cells were observed by using immunohis-tochemical staining method.Inducing chemotherapy was giv-en to all cases to study the relationship between DR5positivi-ty rate and inducing chemotherapy results.RESULTS DR5positivity rate was98%in Jurkat cells with positive signals mainly located in membrane and cytoplasm ......

您现在查看是摘要页,全文长 9763 字符